A Cambridge-based biotech company focused on disrupting the sugar industry to improve human health has been awarded a £60,000 grant by The Eastern Agri-Tech Growth Initiative to invest in the development of its natural sugar substitute technology.
A Cambridge-based biotech company focused on disrupting the sugar industry to improve human health has been awarded a £60,000 grant by The Eastern Agri-Tech Growth Initiative to invest in the development of its natural sugar substitute technology.